PCSA icon

Processa Pharmaceuticals
PCSA

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $75.9K invested in Processa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0.11% less ownership

Funds ownership: 3.24% → 3.14% (-0.11%)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.2K
2
+$12.3K
3
+$10.9K
4
CSS
Cubist Systematic Strategies
Connecticut
+$8.58K
5
Jane Street
Jane Street
New York
+$3.95K

Top Sellers

1
-$20.7K
2
-$3.7K
3
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$21K
UBS Group
2
UBS Group
Switzerland
$13.2K
AGM
3
Alpine Global Management
New York
$10.9K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$10.4K
CSS
5
Cubist Systematic Strategies
Connecticut
$8.58K
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.01K
Jane Street
7
Jane Street
New York
$3.95K
SFA
8
Sequoia Financial Advisors
Ohio
$2.25K
TRCT
9
Tower Research Capital (TRC)
New York
$505
Wells Fargo
10
Wells Fargo
California
$32
Bank of America
11
Bank of America
North Carolina
$22
SS
12
SBI Securities
Japan
$2
AC
13
Armistice Capital
New York
–
MMA
14
Miracle Mile Advisors
California
–